GLP-1 RA Treatment Patterns Among Type 2 Diabetes Patients in Five European Countries
详细信息 查看全文
- 作者：Victoria Divino ; Mitch DeKoven ; Farhad Ali Khan ; Kristina S. Boye…
- 关键词：Exenatide BID ; Exenatide QW ; Diabetes mellitus ; Glucagon ; like peptide 1/analogs and derivatives ; Glucagon ; like peptide 1/therapeutic use ; Type 2/drug therapy ; Liraglutide ; Lixisenatide ; Persistence ; Retrospective studies ; Treatment patterns
- 刊名：Diabetes Therapy
- 出版年：2017
- 出版时间：February 2017
- 年：2017
- 卷：8
- 期：1
- 页码：115-128
- 全文大小：1031KB
- 刊物主题：Internal Medicine; Diabetes; Cardiology; Endocrinology;
- 出版者：Springer Healthcare
- ISSN：1869-6961
- 卷排序：8
文摘
IntroductionGlucagon-like peptide-1 receptor agonists (GLP-1 RAs) are a relatively new class of injectable drugs used in the treatment of type 2 diabetes (T2D). This retrospective database study evaluated real-world treatment patterns of T2D patients initiating GLP-1 RAs in Belgium (BE), France (FR), Germany (DE), The Netherlands (NL) and Sweden (SE).